Glossop, United Kingdom

Michael H Harrison

This inventor holds 1 USPTO granted patent. Top assignee: The University of Manchester. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael H Harrison. Retrieved from https://idiyas.com/inventor/michael-h-harrison

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael H Harrison - Innovator in Lipid Vesicle Particles

Introduction

Michael H Harrison is a notable inventor based in Glossop, GB. He has made significant contributions to the field of biomedical engineering, particularly in the development of lipid vesicle particles. His innovative work focuses on creating targeted delivery systems for therapeutic applications.

Latest Patents

Harrison holds a patent for "Particles - Lipid vesicle particles capable of being targeted to a cell type of interest." This invention incorporates a peptide that responds to specific metabolic signals from targeted cells, modulating the permeability of the particles. The technology has potential applications in detecting cells, treating cells, and therapeutic interventions.

Career Highlights

Michael H Harrison is affiliated with The University of Manchester, where he continues to advance his research in lipid-based delivery systems. His work is recognized for its potential to improve targeted therapies in medicine.

Collaborations

Harrison collaborates with esteemed colleagues, including David J Clarke and Harmesh S Aojula, to further enhance the impact of his research.

Conclusion

Michael H Harrison's innovative work in lipid vesicle particles exemplifies the intersection of science and technology in medicine. His contributions are paving the way for advancements in targeted therapies and cellular treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…